The majority of patients with Saethre-Chotzen syndrome (SCS) present loss-of-function mutations in transcription factor TWIST1 [39, 40] which is thought to negatively regulate FGFR1, 2 and 3 and the osteogenic transcription factor Runx2. This evidence concerns the gene RUNX2 and Saethre-Chotzen syndrome.